Breaking News Instant updates and real-time market news.

BDX

Becton Dickinson

$178.41

-1.32 (-0.73%)

07:13
10/04/16
10/04
07:13
10/04/16
07:13

Becton Dickinson launches Vyaire Medical joint venture

BD announced the launch of a joint venture, Vyaire Medical, a standalone, global respiratory solutions company. The closing finalizes the sale of 50.1% interest in BD's Respiratory Solutions business to funds advised by Apax Partners, a leading global private equity firm. Vyaire Medical includes all business lines within BD's Respiratory Solutions business, including Ventilation, Respiratory Diagnostics, Vital Signs and AirLife, and will have estimated annual revenue of over $800M. BD will retain a 49.9M minority interest in the new company.

BDX Becton Dickinson
$178.41

-1.32 (-0.73%)

05/06/16
LEER
05/06/16
NO CHANGE
Target $175
LEER
Market Perform
Becton Dickinson price target raised to $175 from $157 at Leerink
Leerink analyst Richard Newitter raised his price target for Becton Dickinson to $175 from $157 following a Q2 EPS beat. The analyst thinks guidance remains conservative. Newitter reiterates a Market Perform on the shares.
05/26/16
PIPR
05/26/16
NO CHANGE
PIPR
Piper sees limited impact from new European device tax rules
Piper Jaffray analyst William Quirk points out that the European Union announced it will issue new rules for medical devices and in vitro diagnostics in the near-to-mid term. The EU is looking to strengthen rules for clearing devices/tests for the market and increase existing device/test surveillance, Quirk tells investors in a research note. He believes the new rules should not inhibit well validated tests/devices from coming to market. As such, Quirk expects little impact to Piper's in vitro diagnostic coverage universe, namely Accelerate Diagnostics (AXDX), Becton Dickinson (BDX), Cepheid (CPHD), Hologic (HOLX), Quidel (QDEL) and Meridian Bioscience (VIVO).
09/23/16
SBSH
09/23/16
DOWNGRADE
Target $165
SBSH
Sell
Becton Dickinson downgraded to Sell from Neutral at Citi
Citi analyst Amit Hazan downgraded Becton Dickinson to Sell saying a cyclical U.S. slowdown will drive the company's organic growth below expectations. The analyst also sees a diminishing impact on Becton's growth from emerging markets. He cut his price target for the shares to $165 from $167.
09/23/16
09/23/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Underperform from Sector Perform by RBC analyst Mark Mahaney, who cut his price target to $14 from $17. The research firm's survey of more than 1,100 advertising professionals and their attitudes towards Facebook (FB), Google (GOOG), Twitter and other high-profile names showed that, despite marketing budgets continuing to shift online, interest in the microblog platform appears to be declining. Of note, Twitter shares have surged this morning after CNBC's David Faber reported that Twitter is moving closer to selling itself and has received expressions of interest in a possible sale, although no deal is imminent. 2. Yum! Brands (YUM) downgraded to Outperform from Top Pick by RBC Capital analyst David Palmer based on valuation. His price target on Yum shares remains $97. 3. Becton Dickinson (BDX) downgraded to Sell from Neutral by Citi analyst Amit Hazan, who thinks a cyclical U.S. slowdown will push the company's organic growth below expectations. The analyst, who also sees a diminishing impact on Becton's growth from emerging markets, cut his price target for the shares to $165 from $167. 4. NextEra Energy (NEE) downgraded to Hold from Buy by Deutsche Bank analyst Jonathan Arnold, as he sees limited near-term upside with the shares up 23% year-to-date. "Extraordinarily frosty commentary" from two of three PUCT commissioners yesterday regarding NextEra's Oncor deal indicates an uphill battle in getting it approved, Arnold tells investors. 5. AVANGRID (AGR) downgraded to Underweight from Neutral by JPMorgan analyst Christopher Turnure, who thinks both the company's growth guidance and consensus expectations "appear ambitious." He lowered his price target for the shares to $41 and $44 and notes he does not have confidence in AVANGRID's near-term growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SYT

Syngenta

$92.05

-0.03 (-0.03%)

12:18
09/26/17
09/26
12:18
09/26/17
12:18
Hot Stocks
Syngenta, plaintiffs reach pending settlement in corn traits litigation »

Plaintiffs and defendants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
09/26/17
09/26
12:17
09/26/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
09/26/17
09/26
12:16
09/26/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

$30.44

-0.15 (-0.49%)

12:15
09/26/17
09/26
12:15
09/26/17
12:15
Options
Williams put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
09/26/17
09/26
12:15
09/26/17
12:15
General news
Breaking General news story  »

Atlanta Federal Reserve…

AAPL

Apple

$150.55

-1.34 (-0.88%)

, FIT

Fitbit

$6.54

0.1 (1.55%)

12:08
09/26/17
09/26
12:08
09/26/17
12:08
Hot Stocks
Apple, Fitbit among nine selected for FDA digital pilot program »

The Food and Drug…

AAPL

Apple

$150.55

-1.34 (-0.88%)

FIT

Fitbit

$6.54

0.1 (1.55%)

JNJ

Johnson & Johnson

$131.23

0.06 (0.05%)

RHHBY

Roche

$32.00

-0.02 (-0.06%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 17

    Oct

  • 22

    Oct

  • 30

    Nov

  • 07

    Dec

  • 11

    Dec

OPK

OPKO Health

$6.87

0.16 (2.38%)

12:05
09/26/17
09/26
12:05
09/26/17
12:05
Options
Opko Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

PSO

Pearson

$7.78

-0.04 (-0.51%)

12:03
09/26/17
09/26
12:03
09/26/17
12:03
Downgrade
Pearson rating change  »

Pearson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$31.12

-0.16 (-0.51%)

12:02
09/26/17
09/26
12:02
09/26/17
12:02
Conference/Events
Lionsgate management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 27

    Sep

  • 29

    Sep

LGF.A

Lionsgate

$31.12

-0.16 (-0.51%)

12:00
09/26/17
09/26
12:00
09/26/17
12:00
Conference/Events
Lionsgate management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 29

    Sep

PDS

Precision Drilling

$3.11

0.02 (0.65%)

12:00
09/26/17
09/26
12:00
09/26/17
12:00
Conference/Events
Precision Drilling management to meet with Evercore ISI »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

LUXTY

Luxottica

$55.99

-0.36 (-0.64%)

12:00
09/26/17
09/26
12:00
09/26/17
12:00
Hot Stocks
EU opens in-depth probe into proposed Luxottica, Essilor merger »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
09/26/17
09/26
11:55
09/26/17
11:55
Conference/Events
William Blair medical technology analyst holds analyst/industry conference call »

Medical Technology…

UBNT

Ubiquiti

$55.43

1.25 (2.31%)

11:55
09/26/17
09/26
11:55
09/26/17
11:55
Conference/Events
Ubiquiti to hold a conference call »

Chairman, Founder &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Nov

EA

Electronic Arts

$114.20

-4.3 (-3.63%)

11:50
09/26/17
09/26
11:50
09/26/17
11:50
Options
1.8K Electronic Arts Nov 115 - 125 call spreads for $3.25 »

1.8K Electronic Arts Nov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGT

International Game

$24.32

1.07 (4.60%)

11:45
09/26/17
09/26
11:45
09/26/17
11:45
Options
International Game call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
09/26/17
09/26
11:45
09/26/17
11:45
General news
Treasury's $35 B 4-week bill sale was on the soft side »

Treasury's $35 B…

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

11:38
09/26/17
09/26
11:38
09/26/17
11:38
Recommendations
Axovant Sciences analyst commentary  »

JMP Securities keeps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

HES

Hess Corp.

$46.00

-0.1 (-0.22%)

11:35
09/26/17
09/26
11:35
09/26/17
11:35
Options
Hess Corp. put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

11:35
09/26/17
09/26
11:35
09/26/17
11:35
General news
Breaking General news story  »

Federal Reserve Chair…

11:34
09/26/17
09/26
11:34
09/26/17
11:34
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

RLJE

RLJ Entertainment

$3.38

-0.22 (-6.11%)

11:30
09/26/17
09/26
11:30
09/26/17
11:30
Conference/Events
RLJ Entertainment management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

FPO

First Potomac

$11.15

0.005 (0.04%)

, GOV

Government Properties

$18.76

0.32 (1.74%)

11:30
09/26/17
09/26
11:30
09/26/17
11:30
Hot Stocks
First Potomac shareholders approve acquisition by Government Properties »

First Potomac Realty…

FPO

First Potomac

$11.15

0.005 (0.04%)

GOV

Government Properties

$18.76

0.32 (1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

11:30
09/26/17
09/26
11:30
09/26/17
11:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

MBI

MBIA

$9.57

-0.26 (-2.65%)

11:29
09/26/17
09/26
11:29
09/26/17
11:29
Conference/Events
MBIA management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.